SABCS: San Antonio Breast Cancer Symposium
The San Antonio Breast Cancer Symposium is attended by academic and private researchers and physicians from around the world providing a balance of clinical, translational, and basic research, for those with a special interest in breast cancer.
Measuring Therapeutic Intervention Impact, Receptiveness for Patients With Breast Cancer
December 12th 2019In 3 abstracts presented at the San Antonio Breast Cancer Symposium in San Antonio, Texas, patient-reported outcomes (PROs) and quality of life were measured for different therapeutic interventions aiming to either heighten tumor detection or ease chemotherapy-induced effects.
Read More
Trastuzumab Deruxtecan Demonstrates Durable Efficacy in Phase 2 DESTINY-Breast01 Trial
December 12th 2019Results from the phase 2 DESTINY-Breast01 clinical trial show the novel efficacy of trastuzumab deruxtecan in providing durable benefit to heavily pretreated patients having undergone other HER2-targeted treatments.
Read More
Overall survival was shown to be greater but insignificant in patients administered pertuzumab compared with placebo, while subgroups of lymph node–positive and hormone receptor–negative patients were distinguished as major beneficiaries, according to the results of the second interim analysis of APHINITY presented at the San Antonio Breast Cancer Symposium in San Antonio, Texas.
Read More
